Additionally, we examined CEACAM19 expression across different clinical stages of CRC in the TCGA‐CRC cohort and observed a positive correlation between CEACAM19 expression and the M stage (Figure 6D,P < 0.01). The gene discussed is CEACAM19; the disease is colorectal carcinoma.